Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia
Completed · Not applicable
Conditions studied: Oral Complications of Radiation Therapy, Stage I Laryngeal Cancer, Stage II Laryngeal Cancer
In brief
This pilot trial studies pulsed dye laser in treating patients with post radiation dysphonia. Dysphonia, or vocal cord scarring, can include trouble with the voice when trying to talk, such as hoarseness, change in voice pitch, and poor voice quality, and it commonly happens after radiation therapy for laryngeal cancer. Pulsed dye laser may improve post radiation dysphonia.
Key facts
- Study ID
- NCT02198131
- Run by
- Wake Forest University Health Sciences
- People needed
- 9
- Starts
- 2009-10-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2023-04-26
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients suffering from dysphonia after radiation therapy for glottic carcinoma will be included in the study
- Patients will be included if their initial stage was T1 N0 M0 or T2 N0 M0
You may not qualify if…
- Patients having previously undergone large surgical resections of the larynx or hypopharynx will be excluded
- Patients fewer than 1 year out from completion of radiation therapy will be excluded
- Patients with local disease recurrence would be excluded from the trial
- Patients in whom the transnasal endoscope is poorly tolerated or patients in whom transnasal endoscopic laryngoscopy is contraindicated will be excluded
Where it is running
- Comprehensive Cancer Center of Wake Forest University — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.